Summary: For the first three months of 2007 the Pharmexa Group generated revenues and other operating income of DKK 4,614 thousand and a net loss of DKK 47,886 thousand. Research and development costs totalled DKK 45,658 thousand. The Pharmexa Group retains its forecast for the full year.